Raymond James Financial Inc. Purchases New Position in Humana Inc. (NYSE:HUM)

Raymond James Financial Inc. acquired a new stake in shares of Humana Inc. (NYSE:HUM - Free Report) during the 4th quarter, according to its most recent disclosure with the SEC. The fund acquired 105,313 shares of the insurance provider's stock, valued at approximately $26,720,000. Raymond James Financial Inc. owned approximately 0.09% of Humana as of its most recent filing with the SEC.

Other large investors have also bought and sold shares of the company. FPC Investment Advisory Inc. bought a new stake in shares of Humana in the 4th quarter worth approximately $27,000. Centricity Wealth Management LLC bought a new stake in shares of Humana in the 4th quarter worth approximately $30,000. Ashton Thomas Securities LLC bought a new stake in shares of Humana in the 3rd quarter worth approximately $31,000. Atwood & Palmer Inc. boosted its position in shares of Humana by 64.5% in the 4th quarter. Atwood & Palmer Inc. now owns 153 shares of the insurance provider's stock worth $39,000 after purchasing an additional 60 shares in the last quarter. Finally, Kestra Investment Management LLC bought a new stake in shares of Humana in the 4th quarter worth approximately $49,000. 92.38% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of brokerages have recently commented on HUM. Truist Financial boosted their price target on Humana from $260.00 to $290.00 and gave the stock a "hold" rating in a research report on Monday, January 6th. Morgan Stanley dropped their price target on Humana from $301.00 to $285.00 and set an "equal weight" rating on the stock in a research report on Wednesday, February 12th. JPMorgan Chase & Co. decreased their price objective on shares of Humana from $257.00 to $256.00 and set a "neutral" rating for the company in a report on Tuesday, February 18th. Cantor Fitzgerald restated a "neutral" rating and issued a $290.00 price objective on shares of Humana in a report on Wednesday, February 12th. Finally, Piper Sandler boosted their price objective on shares of Humana from $270.00 to $288.00 and gave the stock a "neutral" rating in a report on Wednesday, January 15th. Nineteen investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. Based on data from MarketBeat, Humana presently has a consensus rating of "Hold" and a consensus price target of $285.68.

Remove Ads

Humana Stock Performance

Humana stock traded up $5.45 during trading on Tuesday, reaching $269.86. The company had a trading volume of 1,632,535 shares, compared to its average volume of 1,713,453. The firm's 50-day simple moving average is $271.39 and its 200 day simple moving average is $278.89. Humana Inc. has a 52 week low of $213.31 and a 52 week high of $406.46. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.68. The firm has a market capitalization of $32.57 billion, a price-to-earnings ratio of 27.12, a price-to-earnings-growth ratio of 2.05 and a beta of 0.57.

Humana (NYSE:HUM - Get Free Report) last released its earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share (EPS) for the quarter, topping the consensus estimate of ($2.26) by $0.10. Humana had a net margin of 1.02% and a return on equity of 11.70%. Sell-side analysts forecast that Humana Inc. will post 16.47 earnings per share for the current fiscal year.

Humana Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, April 25th. Stockholders of record on Friday, March 28th will be given a $0.885 dividend. The ex-dividend date of this dividend is Friday, March 28th. This represents a $3.54 annualized dividend and a dividend yield of 1.31%. Humana's payout ratio is 35.58%.

Insider Transactions at Humana

In other news, insider Timothy S. Huval sold 3,703 shares of the company's stock in a transaction dated Tuesday, December 31st. The stock was sold at an average price of $256.26, for a total value of $948,930.78. Following the completion of the transaction, the insider now owns 8,181 shares of the company's stock, valued at $2,096,463.06. This represents a 31.16 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Corporate insiders own 0.32% of the company's stock.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.